Cargando…
Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway
Tumor growth and metastasis are responsible for breast cancer-related mortality. Andrographolide (Andro) is a traditional anti-inflammatory drug used in the clinic that inhibits NF-κB activation. Recently, Andro has been found in the treatment of various cancers. Andro inhibits breast cell prolifera...
Autores principales: | Li, Junchen, Huang, Lixun, He, Zinan, Chen, Minggui, Ding, Yi, Yao, Yuying, Duan, Youfa, Zixuan, Li, Qi, Cuiling, Zheng, Lingyun, Li, Jiangchao, Zhang, Rongxin, Li, Xiaoming, Dai, Jianwei, Wang, Lijing, Zhang, Qian-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261247/ https://www.ncbi.nlm.nih.gov/pubmed/34249905 http://dx.doi.org/10.3389/fcell.2021.643525 |
Ejemplares similares
-
Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway
por: Yao, Yuying, et al.
Publicado: (2019) -
Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635
por: Yao, Yuying, et al.
Publicado: (2020) -
Andrographolide Inhibits Angiogenesis by Inhibiting the Mir-21-5p/TIMP3 Signaling Pathway
por: Dai, Jianwei, et al.
Publicado: (2017) -
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
por: Lin, Yihua, et al.
Publicado: (2023) -
A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
por: Zhou, Zijun, et al.
Publicado: (2020)